Early stage of lung adenocarcinoma (Lung Nodule)
Conditions
Interventions
Pure ground-glass nodule group:None
Mix ground-glass nodule group:None
Solid nodule group:None
Sponsors
The Second Affiliated Hospital of Army Medical University of the People's Liberation Army of China
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients at stage 0-IA3 who underwent surgical resection and were included in the AJCC 9th edition staging; (2) The postoperative pathological diagnosis of the patient was clearly: lung adenocarcinoma in situ or minimally invasive adenocarcinoma or invasive adenocarcinoma, and our hospital conducted lung cancer-related driver gene testing. (3) Age: 18 to 80 years old; (4) No history of other malignant tumors or anti-tumor treatments such as radiotherapy and chemotherapy in the past; (5) Patients who have been followed up and reexamined in our hospital's outpatient department for more than 2 years after the operation;
Exclusion criteria
Exclusion criteria: (1) The pathological diagnosis is a benign lesion. (2) Patients with postoperative pathological stage IB or above; (3) Patients who have not undergone genetic testing; (4) Patients with other malignant tumors, those who have received neoadjuvant therapy, and those with incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chest CT;Tumor genomic analysis (NGS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological diagnosis;Clinical stage; | — |
Countries
China
Contacts
Public ContactQuanxing Liu
The Second Affiliated Hospital of Army Medical University of the People's Liberation Army of China
Outcome results
None listed